Genetically modified organizations


The alteration of genetic information at the DNA level – genetic modification – is a phenomenon commonly occurring during cell division. Before a cell divides into daughter cells, it must multiply the contents of its organelles (cell “organs”) and also duplicate its genetic information. However, this process also involves rearrangement of the DNA molecule. Such a change can cause the formation, disappearance or change of various properties of the cell or organism. It is this change that makes evolution possible – if the change is positive, this individual will find it “easier to exist”.

All of these processes are mediated in the cell by various enzymes, which are highly specialized proteins. They are present in every living cell and ensure the functioning of virtually the entire metabolism. Enzymes that can modify DNA or RNA are able to find this molecule, cut or glue it, repair various defects and so on.


What happens in cells as a completely natural process, we can simulate to some extent in laboratory conditions. It’s actually a chemical reaction like any other – given the right conditions, substances will react to form products. In the case of genetic modification, the product is usually a DNA molecule that has slightly altered properties compared to the flood. Whether it is a small change at the level of a single “letter” (nucleotide) or whether entire “words” (genes) are changed, added or removed, the principle remains a chemical reaction that can be performed by a cell or a scientist in a laboratory.


An iconic example of inserting several “words” into DNA is golden rice. Rice (Oryza sativa) has had 3 genes added to its genome that modify its metabolism to produce beta-carotene. This is commonly found in carrots, for example, and is interesting because it is a precursor* of vitamin A. This means that if a person consumes vegetables that contain beta carotene, some of it is converted into vitamin A in the body. This is important for proper immune function, vision, reproduction and intercellular communication. However, it plays a major role in childhood development, and its lack of concentration in the diet can even cause blindness.

Vitamin A deficiency is a major problem in developing countries. The traditional method of replenishment is proving to be inefficient and, above all, economically very demanding. Growing golden rice, or other crops containing important micronutrients, is a huge step at LOCAL level in the fight against hunger and malnutrition in developing countries.

Normal and golden rice


It is local farming and home-grown crops that are now being highlighted as the “healthiest” alternative. Plants modified by GMO technology are, on the contrary, condemned because they “have to” grow in the presence of pesticides or antibiotics in huge monocultures.

This myth has arisen because of misinformation surrounding Roundup-ready crops that are able to tolerate this pesticide. Not all genetic modifications cause resistance to something. As mentioned above, genetic modifications can add, subtract or modify genes (words) on a DNA molecule. Whether it will be a gene for pesticide resistance or a gene that causes increased vitamin production depends on the intention under which we are doing the genetic modification in the first place. The technology itself has nothing to do with pesticides! It’s just a matter of how we choose to use it.


Considering the fact that by growing GMO plants we can have much higher yields from the same arable area, the application of this technology also helps in the fight against deforestation. Because less arable land means more preserved natural ecosystems. Not to mention the fact that many plants are not grown for food purposes, but for various other substances, such as rapeseed for biodiesel. By using the right genetically modified bacteria or yeast, it is possible to produce these substances under controlled conditions in fermentation facilities on various food production wastes, thus further saving nature.

In the next article we will move from plants to animals and gene therapy.

New member of the expert board – MUDr. Alena Zumrová, Ph.D

We are incredibly honoured to welcome a new addition to our team on the expert board. We greatly appreciate the doctor for her lifetime of experience in neurology and her willingness to support patient efforts.

Our core mission is to bridge the worlds of science, medicine and patients. Thanks to the doctor, that will be a little easier again. As a first goal, she and I set out to find out the current real number of patients with Angelman syndrome in the Czech Republic. If you were surprised that such an elementary figure is missing, it is indeed a sad fact. There is no institution in the Czech Republic that is obliged to publish such data. However, knowing the most accurate number of patients is essential for any further action. All in accordance with GDPR, of course, we are concerned with an anonymised aggregate count of all patients like Oliver.

Doctor, welcome to the team. We’re really excited about this.

MUDr. Alena Zumrová, Ph.D.

She has been working since 1982 at the Department of Child Neurology at the 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital in Prague.In 2008, she founded the Motol University Hospital Hereditary Ataxia Centre with nationwide coverage, which in 2018 was awarded the status of a reference centre within the European Reference Network for Rare Neurological Diseases (ERN-RND). It focuses on neurodevelopmental, neurometabolic, neurodegenerative and neurogenetic rare diseases.

What are cell and gene therapies and how do they work?

Transformative cell and gene therapies represent a new frontier of medicine.They offer hope for many patients, particularly those affected by rare diseases. Gene therapies are a success story of the 21st century, with exciting treatment options in the pipeline for many diseases, such as rare bleeding disorders or different forms of neuromuscular disorders. Likewise, cell-based products are offering new hope for several conditions (e.g. CAR-Ts for certain blood cancers).

Cell and gene therapies have fundamentally different properties than medicines and surgery in that they treat the core underlying genetic causes of a disease rather than treating symptoms.


Gene therapy is the use of genetic material to treat genetic diseases. This may involve adding or replacing a wild type copy of the gene (gene addition or gene replacement) or altering a gene with mutation to the wild type gene (gene editing). The treatment may take place outside of the body (ex vivo) or inside the body (in vivo).


Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. The cells may originate from the patient (autologous cells) or a donor (allogeneic cells). The cells used in cell therapy can be classified by their potential to transform into different cell types. Pluripotent cells can transform into any cell type in the body and multipotent cells can transform into other cell types, but their repertoire is more limited than that of pluripotent cells.